GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » Debt-to-EBITDA

SPO Global (SPO Global) Debt-to-EBITDA : 0.06 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is SPO Global Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SPO Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.27 Mil. SPO Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. SPO Global's annualized EBITDA for the quarter that ended in Sep. 2023 was $4.36 Mil. SPO Global's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SPO Global's Debt-to-EBITDA or its related term are showing as below:

SPOM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -9.53   Med: -1.42   Max: 1.41
Current: 0.25

During the past 13 years, the highest Debt-to-EBITDA Ratio of SPO Global was 1.41. The lowest was -9.53. And the median was -1.42.

SPOM's Debt-to-EBITDA is ranked better than
89.13% of 414 companies
in the Conglomerates industry
Industry Median: 3.115 vs SPOM: 0.25

SPO Global Debt-to-EBITDA Historical Data

The historical data trend for SPO Global's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global Debt-to-EBITDA Chart

SPO Global Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.89 -2.88 -2.30 -6.81 -9.53

SPO Global Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep22 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.28 -6.92 -14.15 N/A 0.06

Competitive Comparison of SPO Global's Debt-to-EBITDA

For the Conglomerates subindustry, SPO Global's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SPO Global's Debt-to-EBITDA Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, SPO Global's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SPO Global's Debt-to-EBITDA falls into.



SPO Global Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SPO Global's Debt-to-EBITDA for the fiscal year that ended in Dec. 2016 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.436 + 0.261) / -0.178
=-9.53

SPO Global's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.272 + 0) / 4.36
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


SPO Global  (OTCPK:SPOM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SPO Global Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SPO Global's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SPO Global (SPO Global) Business Description

Traded in Other Exchanges
N/A
Address
Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634
SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.
Executives
Jeffrey Louis Feuer officer: Chief Financial Officer 21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan officer: Chief Operating Officer 21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold director, officer: Chief Executive Officer C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun director SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman director 183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi 10 percent owner, officer: Chief Technology Officer C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367